QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 20, Issue 1, 509-520, January 1, 2009

This Article Abstract Full Text (PDF) Supplemental Materials All Versions of this Article: E08-03-0274v1 20/1/509    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Urish, K. L. Articles by Huard, J. Search for Related Content PubMed PubMed Citation Articles by Urish, K. L. Articles by Huard, J.

Antioxidant Levels Represent a Major Determinant in the Regenerative Capacity of Muscle Stem Cells

Kenneth L. Urish^*,, Joseph B. Vella^,, Masaho Okada, Bridget M. Deasy^,,||, Kimimasa Tobita^¶, Bradley B. Keller^¶, Baohong Cao, Jon D. Piganelli^¶, and Johnny Huard^,,||,#

*Department of Orthopaedics and Rehabilitation, and Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, PA, 17033; Departments of Bioengineering, ^||Orthopaedic Surgery, and ^#Molecular Genetics and Biochemistry, University of Pittsburgh, Pittsburgh, PA, 15260; and Stem Cell Research Center, Rangos Research Center and ^¶Department of Pediatrics, Children's Hospital of Pittsburgh, PA 15213

Submitted March 14, 2008; Revised October 20, 2008; Accepted October 31, 2008
Monitoring Editor: J. Silvio Gutkind

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Stem cells are classically defined by their multipotent, long-term proliferation, and self-renewal capabilities. Here, we show that increased antioxidant capacity represents an additional functional characteristic of muscle-derived stem cells (MDSCs). Seeking to understand the superior regenerative capacity of MDSCs compared with myoblasts in cardiac and skeletal muscle transplantation, our group hypothesized that survival of the oxidative and inflammatory stress inherent to transplantation may play an important role. Evidence of increased enzymatic and nonenzymatic antioxidant capacity of MDSCs were observed in terms of higher levels of superoxide dismutase and glutathione, which appears to confer a differentiation and survival advantage. Further when glutathione levels of the MDSCs are lowered to that of myoblasts, the transplantation advantage of MDSCs over myoblasts is lost when transplanted into both skeletal and cardiac muscles. These findings elucidate an important cause for the superior regenerative capacity of MDSCs, and provide functional evidence for the emerging role of antioxidant capacity as a critical property for MDSC survival post-transplantation.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Myogenic cell transplantation has been proposed as a promising therapeutic approach in the treatment of skeletal and cardiac muscle injury. Early studies of myoblast transplantation into dystrophic skeletal muscle yielded limited regeneration of dystrophin-expressing muscle fibers (Beauchamp et al., 1994; Gussoni et al., 1997; Qu-Petersen et al., 2002). Similarly, given the limited regenerative ability of cardiac muscle, cell transplantation has been proposed as an alternative to heart transplantation (Assmus et al., 2006; Lunde et al., 2006; Schachinger et al., 2006).

A major obstacle in both cardiac and skeletal myogenic therapies is the poor rate of engraftment of myogenic cells after transplantation (Taylor et al., 1998; Oshima et al., 2005). In skeletal muscle, numerous groups have observed a rapid inflammatory response that appears to contribute to rapid cell loss and limit therapeutic success (Beauchamp et al., 1994; Gussoni et al., 1997; Beauchamp et al., 1999). Multiple groups have postulated that the small number of injected cells that survive transplantation in both cardiac and skeletal muscle may represent a special subpopulation of stem-like cells (Qu et al., 1998; Beauchamp et al., 1999; Qu-Petersen et al., 2002).

For these reasons, our group attempted to isolate this putative subpopulation of cells using a modified preplate technique. This procedure was initially developed to purify myoblasts from nonmyogenic cells, including fibroblasts, of whole tissue preparations based on the differential adhesion characteristics of the cells to a collagen coated flask (Rando and Blau, 1994). Our group modified this technique to isolate various populations of myogenic cells, including a population of early adhering preplate (EP) cells and a late adhering preplate (LP) cell population from which a subpopulation of long-term proliferating (LTP) cells, also known as muscle derived stem cells (MDSCs), has been isolated (Gharaibeh et al., 2008). Although it should be noted that both myoblasts and MDSCs fuse to one another and with host endogenous myofibers, forming dystrophin(+) myofibers, MDSCs demonstrate a superior ability to regenerate skeletal muscle fibers (Jankowski et al., 2001; Qu-Petersen et al., 2002). Similarly, MDSCs injected into hearts after myocardial infarction improve cardiac function to a greater extent than transplanted myoblasts (Oshima et al., 2005; Payne et al., 2007).

MDSCs differ from myoblasts not only in their cell marker expression but also in their behavior, which includes: long-term proliferation, multipotency, self-renewal ability, and their high regenerative capacity. It should be noted that MDSCs are isolated based on their late adhesion characteristics and not on their cell marker expression. Although their cell marker profile has been characterized subsequent to preplate isolation (Jankowski et al., 2001, 2002; Jankowski and Huard, 2002; Deasy et al., 2005, 2007), their designation as stem cells is multifactorial. It is predicated on their multipotency, their cell marker expression, their self-renewal abilities, and most importantly by their significantly increased regenerative capacity when compared with myoblasts (Qu-Petersen et al., 2002; Oshima et al., 2005). In fact, the least reliable method for their appropriate designation as stem cells has been their maintenance of a stable marker profile. Myoblasts, on the other hand, differ significantly from MDSCs in that they cannot usually be cultured for long periods of time due to their rapid differentiation into myotubes, they express the late myogenic cell marker Pax7 (unlike MDSCs), and they engraft poorly when transplanted into the skeletal muscle of mdx mice.

CD34 and Sca1 cell marker expression in MDSCs has been shown to be influenced by cell culture even after clonal isolation. Although other groups have used cell markers to isolate a multipotent cell fraction from skeletal muscle, the CD34 and Sca-1 marker profiles of MDSCs are heterogeneous (Jankowski et al., 2001, 2002). When MDSCs are sorted using fluorescence-activated cell sorting (FACS) by their CD34 and Sca-1 expression, heterogeneity is reestablished after in vitro culture. Furthermore, we have found using FACS-sorted and clonal populations of MDSCs, that expression of these two cell markers does not exclusively predict the engraftment size of dystrophin-(+) myofibers or regeneration index (RI = number of dystrophin(+) myofibers/number of cells transplanted) in dystrophin deficient, mdx mice (Jankowski et al., 2001; Qu-Petersen et al., 2002; Deasy et al., 2005, 2007).

Several groups have isolated stem cell and early progenitor populations from skeletal muscle based on differential adhesion and cell marker expression (Young et al., 2001; Gharaibeh et al., 2008). More recently, a skeletal muscle precursor population was isolated via FACS sorting CD45^–, Sca1, Mac1, CXCR4⁺, and β1 integrin⁺ subpopulations of satellite cells (Cerletti et al., 2008), and a myogenic endothelial cell population in skeletal muscle was initially reported based on CD34⁺ and CD45^– expression, which was shown to improve cardiac function after myocardial infarction (Tamaki et al., 2002, 2008a). Tamaki et al. (2007, 2008b) have also clonally isolated so-called skeletal double-negative cells (Sk-DN), which are CD34^–/CD45^–, and have demonstrated their multipotency in vitro and in vivo. Our group has reported a similar population of so-called myoendothelial cells isolated from human skeletal muscle based on their coexpression of CD56, CD34, and CD144 (Zheng et al., 2007). Furthermore, pericytes isolated from skeletal muscle also display a high regeneration index in skeletal muscle similar to myogenic endothelial cells and MDSCs (Dellavalle et al., 2007; Crisan et al., 2008), which has led to the hypothesis that all of these populations may originate from a blood vessel wall niche in skeletal muscle (Tamaki et al., 2002; Tavian et al., 2005; Peault et al., 2007).

Defined by their properties to differentiate into multiple tissue types, their propensity for self-renewal, and their capacity for long-term proliferation, stem cells promise to pave the way for potential cell therapies in the future; however, oxidative, inflammatory, and other cell stress associated with transplantation can restrict the regenerative capacity of these cells. Emerging evidence of increased antioxidant capacity as a characteristic of stem cells suggests a further justification for the pursuit of stem cell therapies. Stem cells may possess an ability to avoid the oxidative damage to which their more differentiated counterparts, such as myoblasts, are more vulnerable (Dernbach et al., 2004; He et al., 2004).

The presence of inflammation at the site of transplantation in both injured and diseased skeletal and cardiac muscle suggests that inflammatory and oxidative stress may play an important role in the regenerative potential of a given cell population (Beauchamp et al., 1994; Huard et al., 1994; Mendell et al., 1995; Fan et al., 1996; Gussoni et al., 1997; Urish et al., 2005). Inflammation, the associated release of proinflammatory cytokines, and oxidative stress have been associated with multiple types of cell transplantation, including myoblast transplantation into skeletal and cardiac muscle (Suzuki et al., 2004; Urish et al., 2005), transplantation of pancreatic islets (Bottino et al., 2004), and bone marrow transplantation (Blackwell et al., 2000; Evens et al., 2004). The destructive power of oxygen is a major component of inflammation through its ability to strip electrons and form highly reactive oxygen species (ROS). After cell transplantation, inflammation via the secretion of cytokines, recruitment of inflammatory cells, and vascular exudation can induce mechanical perturbation of the microvascular barrier and local ischemia (Gute et al., 1998; Carden and Granger, 2000). Ischemia and the associated reperfusion injury is directly linked to the production of various ROS (Kaminski et al., 2002). In addition to the respiratory burst of inflammatory cells such local ischemia can further induce ROS production via xanthine oxidase conversion from xanthine dehydrogenase.(Chanock et al., 1994; Nishino, 1994; Gute et al., 1998; Makazan et al., 2007).

Multiple groups have shown that stem cells appear to have an increased antioxidant capacity (Dernbach et al., 2004; He et al., 2004), whereas others have demonstrated the deleterious role of inflammation and oxidative stress in cell transplantation (Qu et al., 1998; Suzuki et al., 2000). Our group has shown that MDSCs have lower rates of stress-induced cell death, and we have speculated that the MDSCs' increased regenerative capacity may relate to an increased resistance to oxidative and inflammatory stress (Oshima et al., 2005; Deasy et al., 2007). In this article, we extend this work and hypothesize that the MDSCs' increased antioxidant capacity may be responsible for the increased regeneration capacity of these cells when compared with myoblasts.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Cell Isolation and Culture
MDSCs were isolated from the skeletal muscle of 3-wk-old C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) as previously described using a modified version of the preplate technique (Qu-Petersen et al., 2002; Gharaibeh et al., 2008). Myoblasts were isolated from 1–3-wk-old C57BL/6J mice using this same method as previously described (Qu-Petersen et al., 2002; Gharaibeh et al., 2008). All cells were cultured and expanded in high-serum proliferation media (DMEM, 10% fetal bovine serum, 10% horse serum, 1% penicillin/streptomycin, and 0.5% chick embryo extract). Myoblasts were cultured for <8 passages before each experiment. The MDSCs that were used for the transplantation experiments were all 20 passages. It is important to note that recent work has shown that MDSCs can be cultured past the Hayflick limit of 200 doublings while preserving their regeneration index and not exhibiting any abnormal neoplastic transformation properties (Lee et al., 2000; Deasy et al., 2002, 2003, 2005, 2007).

Fusion Index
The rate and extent of myoblast and MDSC fusion into syncytial myotubes was monitored after a single 24 h exposure to H₂O₂ or TNF- to simulate an oxidative or inflammatory stress challenge. Cells were plated at an initial density of 1250 cells/cm² and cultured in high-serum proliferation media. After 48 h, the culture medium was replaced with low-serum medium (DMEM, 2% fetal bovine serum, and 1% penicillin/streptomycin) to induce differentiation. At this point H₂O₂ (10, 25, 50, and 100 µM; Sigma, St. Louis, MO) and TNF- (1.0, 2.5, and 5.0 ng/ml; R&D Systems, Minneapolis, MN) was added. Media were replaced daily with fresh differentiation media (without H₂O₂ or TNF-).

At days 3 and 4, the cells were fixed in cold methanol and evaluated for the presence of skeletal fast myosin heavy chain-positive myotubes (1:400, MY-32 clone, Sigma) and counterstained with DAPI (1:1000, Sigma). Fluorescence microscopy was performed on a Leica DMIRB microscope (Deerfield, IL) with a Retiga 1300 digital camera (QImaging, Burnaby, BC, Canada). All images were acquired with Northern Eclipse software (version 6.0; Empix Imaging, Mississauga, ON, Canada).

These images were used to measure the fusion index (Jankowski et al., 2002), defined as the ratio of the total number of nuclei in myosin-heavy-chain–expressing cells compared with the total number of nuclei of the entire cell population. Each dose- and time-dependent experiment was performed in triplicate using six randomly selected microscope fields for quantification in each experiment.

Additional experiments to test the effects of sustained inflammatory stress (TNF-) on myogenic differentiation were conducted in an identical manner as described above with the following changes. Fresh differentiation medium with 5.0 ng/ml TNF- was exchanged daily in each cell population. The fusion index was measured on days 3, 4, and 7.

Cell Death
MDSCs and myoblasts were cultured for 24 h under normal culture conditions and then incubated in H₂O₂ (100, 250, and 500 µM) at 37°C. After 15 h, the media were collected; cells were washed in PBS, harvested in 0.01% trypsin-EDTA (Invitrogen Laboratories, Carlsbad, CA), and resuspended in proliferation media. The number of apoptotic and necrotic cells was measured by staining the cells with annexin-V and propidium iodide according to manufacturer's directions (BD Bioscience, San Jose, CA) and quantifying their numbers using FACS (FACSAria; FACSDiva Software; BD Bioscience) with standard calibration and one-color control for compensation of fluorochromes. Total cell death was determined as the sum of necrotic and apoptotic cell death fractions normalized to exclude cellular debris.

To monitor the rate of cell death over a continuous time period, a modified live cell microscopy technique was used to measure percentages of annexin-V–positive cells. Cells were seeded at an initial density of 2000 cells/cm² on collagen Type-I 24-well plates and cultured for 24 h. Cells were loaded with Cell Tracker Red-CMTPX (Molecular Probes, Eugene, OR) according to manufacturer's directions to aid in segmentation of the entire cell population. Cells were then placed in proliferation media containing 15 µg/ml annexin-V FITC (BD Bioscience) and 10 µg/ml propidium iodide. A microscope imaging system (Kairos, Harmarville, PA) was used to acquire light and fluorescent time-lapsed images on a 30-min time interval (Deasy et al., 2002; Bahnson et al., 2005). At each time point, nine images in each plate were collected, resulting in over 45,000 images and 1–3 x 10⁵ total events being recorded. After an initial baseline measurement was collected, cells were incubated with increasing doses of H₂O₂ (10, 25, 50, 100, 250, and 500 µM; Sigma) and TNF- (1.0, 2.5, and 5.0 ng/ml; R&D Systems). Images were collected on a 30-min interval over a 24-h period. The percentages of annexin-positive cells in each population at each time period were measured using open source software.

Antioxidant Capacity
The antioxidant capacity of each cell population was assessed by measuring the levels of reduced glutathione (GSH), superoxide dismutase (SOD) activity, and intracellular ROS after H₂O₂ challenge. Levels of ROS were measured using 5-(and-6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate (carboxy-H₂DCFDA; Molecular Probes). Briefly, cells were plated at 2500 cells/cm² and after 48 h were loaded with 5 µM carboxy-H₂DCFDA for 30 min in proliferation media, washed, and exposed to 500 µM H₂O₂. At 15-min time intervals, cells were harvested and green fluorescence was immediately measured using flow cytometry (Hempel et al., 1999).

Levels of GSH were monitored using monochlorobimane (MCB; Molecular Probes), a nonfluorescent bimane that reacts with free GSH to form a highly fluorescent derivative. Cells were loaded with 4 µM of MCB for 30 min in proliferation media, harvested, washed, and the fluorescence was measured using FACS with single parameter controls.

Total activity of SOD was measured using a colorimetric assay (Chemicon, Temecula, CA; APT290). Myoblast and MDSC cell samples containing 2 x 10⁶ cells were homogenized using a lysis buffer (10 mM Tris, pH 7.5, 150mN NaCl, 0.1 mM EDTA, and 0.5% Triton X-100) and centrifuged at 12,000 x g for 10 min to collect cell lysate. SOD activity was measured according to manufacturer's directions.

GSH Depletion
To assess the role of GSH in regenerative capacity, MDSCs were depleted of cellular GSH using diethyl maleate (DEM, Sigma), which conjugates directly with GSH and renders it inactive (Plummer et al., 1981). After 48 h in standard culture conditions, cells were treated with 50 µM DEM for 2 h, washed twice in PBS, and then cultured in fresh proliferation media. In some in vitro experiments, other concentrations of DEM were used using the same protocol where noted in the results section.

Cell Transplantation
All animal surgical procedures were approved by The Institutional Animal Care and Use Committee, Children's Hospital of Pittsburgh (Protocol 7/03). MDSCs and myoblasts were injected into Mdx mice as previously described (Lee et al., 2000; Qu-Petersen et al., 2002). Briefly, 2 x 10⁵ viable cells suspended 30 µl of PBS were injected into the gastrocnemius muscle of 4–6-wk-old Mdx mice (C57BL/10ScSn DMDmdx/J, The Jackson Laboratory). The mice used in the experiment were not immunosuppressed, and the injected muscle was not injured nor irradiated before or after cell transplantation. These methods were not used because in our experience immune suppression and muscle injury (via irradiation or cardiotoxin injection) are not required for large engraftments of the MDSCs (Qu-Petersen et al., 2002; Deasy et al., 2007; Cerletti et al., 2008). Because the myoblasts and MDSCs were isolated from inbred mice with identical backgrounds (C57BL/6J) and are injected into inbred host mdx mice, any immunological response elicited by the injected cells should be identical unless the cell type injected is exhibiting an immunologically privileged behavior—a behavior that is, indeed, exhibited by stem cells (Qu-Petersen et al., 2002).

Coronary artery ligation and cell transplantation into infarcted hearts were performed in 14-wk-old C57BL/6J mice (Jackson Laboratory), and physiological function was measured as previously described (Oshima et al., 2005; Payne et al., 2007). Briefly, myocardial infarctions were induced by ligating the left anterior descending coronary artery. Cells (3 x 10⁵) or PBS were injected into the anterior, center, and lateral aspects of the infracted myocardium. Echocardiography (Sequoia C256 system; Siemens, Malvern, PA) was performed at 6 wk to assess the systolic function. Two-dimensional images of the heart were obtained at the midpapillary muscle level. The end-diastolic area (EDA) and end-systolic area (ESA) were measured from short-axis images of the left ventricle. The end-diastolic dimension (EDD) and end-systolic dimension (ESD) were measured from at least six consecutive beats from an M-mode tracing. Systolic function was assessed by measuring the fractional shortening (FS) and fractional area change (FAC), a measure of the change in length and area of the myocardium during systole, respectively, that represents the degree of muscle contraction. FS is defined as [(EDD – ESD)/EDD], and the FAC is defined as [(EDA – ESA)/EDA].

Histological Analysis
Skeletal muscle sections were stained for dystrophin (1:50, Dys-2, Novocastra, Burlingame, CA) using protocols previously described (Deasy et al., 2007). Infarct scar on cardiac sections were stained using Mason's Modified IMEB Trichrome Stain Kit (International Medical Equipment, San Marcos, CA) according to manufacturer's instructions. A mouse anti-fast skeletal myosin heavy-chain (MHC) antibody (1:400, MY-32 clone, Sigma) and a rat anti-mouse CD31 antibody (1:1000, Becton Dickinson Pharmingen, San Diego, CA) was used to immunostain cardiac muscle sections for myofibers and capillaries as previously described (Oshima et al., 2005; Payne et al., 2007). Fluorescence and bright field microscopy was performed using Nikon Eclipse E800 microscope (Melville, NY) equipped with a Retiga Exi digital camera (QImaging). All images were acquired with Northern Eclipse software (version 6.0; Empix Imaging).

The scar tissue ratio was measured from digital images collected at low power (20x) of the entire left ventricle cross section after staining with Mason's trichrome. Scar tissue ratio was measured as the number of pixels in the area of fibrosis to the number of pixels in the entire area of the left ventricle cross section (six sections/animal). Myofiber engraftment size was measured as the total number of pixels in the skeletal myofiber engraftment on the cardiac cross section. The largest engraftment was used for each animal was used for this measurement. We measured the capillary density by counting the number of CD31+ capillary structures per high-power field (200x) within the infarct and MHC+ area (six images/animal).

Image Analysis
Image analysis using computing software was conducted as noted above to measure rates of apoptosis over a continuous time period and to measure the fusion index. All programs, except where noted, were written as open source, freely available code using the Insight Toolkit, an image segmentation and registration C++ code library (Yoo et al., 2002). The area of MHC expression, the scar tissue ratio, and the capillary density in the induced myocardial infarction animal model were measured using ImageJ (version 1.23j, National Institute of Health; http://rsb.info.nih.gov/ij/).

Statistical Analysis
Data are expressed as a mean ± SE, except where noted. Direct comparisons between two cell populations were made using an unpaired, two-tailed Student's t test. Statistical significance was determined if p < 0.05. All statistical tests were completed using R (R Core Development Team, www.r-project.org). Comparisons of single groups were completed using one-way ANOVA. Multiple group comparisons were made using two-way ANOVA. In both cases, significance levels were determined using the Student-Newman-Keuls pairwise comparison.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
MDSCs Have Less Oxidative and Inflammatory Stress–induced Cell Death
Given that MDSCs have demonstrated an increased regenerative capacity in both skeletal and myocardial muscle (Qu-Petersen et al., 2002; Oshima et al., 2005), we hypothesized that the inflammatory response observed at the site of transplantation is a major determinant in the differential regenerative capacity of MDSCs and myoblasts. Our primary objective was to determine if a differential resistance to oxidative (H₂O₂) or inflammatory (TNF-) stress could be observed in vitro between the two cell populations, in terms of survival, differentiation, and antioxidant capacity.

To test this hypothesis in terms of survival, myoblasts and MDSCs were exposed to H₂O₂ (100, 250, 500 µM) in vitro for a period of 18 h to determine if MDSCs have a survival advantage after oxidative stress. The early apoptotic marker, annexin-V, and the later apoptotic marker, propidium iodide exclusion, were used to measure total cell death using FACS. Myoblasts had significantly higher rates of cell death compared with MDSCs at each dose tested (p < 0.05; Figure 1A), suggesting that MDSCs were more resistant to oxidative stress–induced cell death after 18 h of exposure. A limiting factor in these experiments was the ability to only collect a limited series of measurements at one time point.

View larger version (30K): [in this window] [in a new window]   Figure 1. MDSCs have lower rates of cell death after exposure to H2O2 and the inflammatory cytokine TNF- than myoblasts. (A) Total levels of apoptosis and necrosis were measured at 18 h after exposure to H2O2 using flow cytometry with annexin-V and propidium iodide staining. (B) Levels of cell death were measured over a continuous 36 h period using time-lapse imaging with annexin-V staining after exposure to 50 µM H2O2. Solid lines represent the mean fraction of annexin-V-positive cells, whereas the range-plot represents the 95% confidence interval (CI) of these measurements. (C and D) Using the approach outlined in B, levels of annexin-V staining over a 24 h period were monitored after exposure to increasing doses of H2O2 (C) and TNF- (D). ANOVA; *p 0.05; mean values ± CI shown.

A similar MDSC survival advantage was observed when both cell populations were exposed to increasing doses of the inflammatory cytokine TNF- (1.0, 2.5, 5.0 ng/ml), using the same robotic live-cell microscopy system. A representative summary of these results at 18 h reveals that myoblasts have significantly higher rates of cell death than MDSCs at all doses (p < 0.05; Figure 1D). These results mirror the observations from measuring cell death after exposure to H₂O₂.

MDSCs Maintain the Ability to Differentiate After Oxidative Stress
The capacity of a cell population to differentiate is an important measure of how well the cell may engraft to and/or induce regeneration of the host muscle. Therefore, a survival advantage of MDSCs alone may not be sufficient for their superior regenerative capacity in skeletal and cardiac muscle. We hypothesized that MDSCs would maintain their ability to differentiate into myotubes after exposure to oxidative and inflammatory stresses better than myoblasts. Myogenic differentiation of both MDSC and myoblast cell populations were measured after exposure to both H₂O₂ and TNF-. After high-density culture in low serum media to induce differentiation, cells were exposed to either H₂O₂ (10, 25, 100 µM) or TNF- (1.0, 2.5, 5.0 ng/ml) for 24 h. After this 24 h stress challenge, the low-serum media were exchanged on a daily basis. (Note: H₂O₂ and TNF- were not included in the media after the stress challenge). Differentiation was quantified at 3 and 4 d after treatment using the fusion index, which is defined as the ratio of the total number of nuclei in fast MHC-expressing cells, a late differentiation myogenic protein, to the total number of nuclei.

Large differences between the ability of MDSCs and myoblasts to form myotubes after exposure to oxidative and inflammatory stresses were observed at day 3. Representative images of MDSCs and myoblasts exposed to 100 µM H₂O₂, and untreated controls show that MDSCs maintained similar rates of myogenic differentiation after H₂O₂ exposure, whereas myoblasts had a substantial decrease in myogenic differentiation (Figure 2A). Although the fusion index of MDSCs remained constant at increasing doses of H₂O₂, myoblasts had a significant and progressive dose-modulated decrease in their fusion index (p < 0.05; Figure 2B). A similar response was measured when both cell populations were exposed to TNF- (p < 0.05; Figure 2C). In both cases, the dose response behavior was temporary, given that by day 4, no difference in the rate of differentiation of myoblasts or MDSCs was observed (Supplemental Figure S1).

View larger version (37K): [in this window] [in a new window]   Figure 2. Oxidative and inflammatory stress delays differentiation in myoblasts but not in MDSCs. (A) Representative images of the MHC expression (red) of MDSCs and myoblasts at day 3 after a 24 h exposure to H2O2 (nuclei stained with dapi in blue) are shown. (A) Bar, 50 µm. (B) At day 3, MDSCs exposed to H2O2 displayed similar rates of differentiation as untreated MDSC controls. Myoblasts displayed less differentiation than myoblast controls. Results were similar with exposure to TNF-. (C) At day 3, MDSCs exposed to TNF- displayed similar rates of differentiation as untreated MDSC controls. Myoblasts displayed less differentiation than myoblast controls. (D) Myoblast differentiation inhibited on daily exposure to TNF- (5 ng/ml), whereas MDSC differentiation is unaffected. Data are expressed as an FI ratio of stressed and unstressed cell groups. (B–D) ANOVA; *p 0.05; mean values ± SEM.

MDSCs Exhibit Lower Levels of Intracellular ROS
Given that MDSCs had lower rates of cell death and maintained their ability to differentiate compared with myoblasts after exposure to oxidative stress, we hypothesized that these differences in survival would correlate with the cells' sustaining differential oxidative damage. We monitored the levels of intracellular ROS in MDSCs and myoblasts after exposure to a high dose of H₂O₂ (500 µM) using FACS with the fluorescent indicator carboxy-H₂DCFDA over a 2 h time period. Our results indicate that myoblasts had a significant peak in intracellular ROS concentration 30 min after H₂O₂ exposure that was sevenfold higher than that of MDSCs for the same time point (p < 0.05; Figure 3A).

View larger version (12K): [in this window] [in a new window]   Figure 3. MDSCs have lower degrees of oxidative damage and a higher antioxidant capacity than myoblasts. (A) Measured intracellular ROS levels after exposure to 500 µM H2O2 for 2 h. MDSCs had little increase in ROS, whereas myoblasts had a large increase. (B) MDSCs have higher levels of GSH as shown by the mean fluorescence after MCB staining. (C) MDSCs had a significantly higher total SOD activity than myoblasts. (B and C) Student's t test; *p 0.05; mean values ± SEM.

As an initial study of the sources of MDSCs' increased antioxidant capacity, we sought to investigate the activity of GSH and SOD. Basal concentrations of GSH were measured using FACS after staining with monochlorobimane (MCB). MDSCs had a 2.5-fold increase in mean fluorescence, revealing that the differences in GSH levels are significant (p < 0.05; Figure 3B). Total SOD activity was measured using a colorimetric assay. MDSCs had a 0.5-fold higher level of total basal SOD activity when compared with myoblasts (p < 0.05; Figure 3C). These experiments combined with MDSCs having lower levels of ROS after exposure with H₂O₂ suggest that MDSCs have an increased antioxidant capacity when compared with myoblasts.

Decreasing the GSH Levels of MDSCs Decreases the Regeneration Capacity of MDSCs in Skeletal Muscle
To assess the role antioxidant capacity plays after cell transplantation in vivo, we decreased the MDSC GSH levels to that similar to myoblasts and measured the regenerative capacity of the cells after injection into the gastrocnemius muscles of Mdx mice. For this purpose, cells were exposed to DEM, a specific, nonprotein thiol-depleting agent that selectively inhibits glutathione activity (Plummer et al., 1981). After exposure to increasing doses of DEM, the basal levels of GSH were measured by MCB fluorescence using flow cytometry. DEM concentrations of 10 or 50 µM were found to reduce the level of GSH in MDSCs to levels comparable to those in myoblasts (Figure 4, A and B). To ensure that the overall antioxidant capacity of MDSCs had been reduced to that comparable to myoblasts, oxidative stress experiments using the live cell microscopy system were repeated using DEM-treated (50 µM) MDSCs and myoblasts both under conditions of H₂O₂ stress (100 µM). Indeed the DEM-treated MDSCs had similar rates of cell death as the myoblast population across multiple time points (Figure 4, C and D). Thus, 50 µM of DEM was selected to inhibit MDSCs' resistance to oxidative stress and make the MDSCs comparable to myoblasts in terms of antioxidant capacity for the remainder of the in vivo experiments.

View larger version (16K): [in this window] [in a new window]   Figure 4. Decreasing the levels of GSH in MDSCs, by treatment with DEM, decreases the MDSCs' resistance to stress. (A) Histogram plots of GSH levels of MDSCs treated with increasing doses of DEM (0, 5, 10, 50 µM) compared with untreated myoblasts. (B) The median fluorescence of the groups in A is shown for clarity. (C) Rates of cell death for MDSCs treated with 50 µM DEM, untreated MDSCs, and untreated myoblasts after exposure to 100 µM H2O2. The area associated with each line represents the 95% CI of the respective mean. Untreated MDSCs were included for reference; the CI of this group is not included to increase visual clarity. (D) Six-hour interval snapshots of C indicate that MDSCs treated with DEM have rates of oxidative stress–induced cell death comparable to that of myoblasts, and both groups have higher rates of cell death compared with MDSCs. ANOVA; *p 0.05; mean values ± CI are shown, except in B where the median value ± SEM is shown.

View larger version (29K): [in this window] [in a new window]   Figure 5. Decreasing the antioxidant capacity of MDSCs decreases the ability of MDSCs to regenerate dystrophin-positive myofibers. MDSCs treated and untreated with 50 µM of DEM and myoblasts were injected into the skeletal muscle of Mdx mice that were sacrificed at 2 wk, and the regeneration index (RI) was measured. (A–C) Representative images of the dystrophin-positive engraftments of MDSCs, skeletal muscles treated with MDSCs, and myoblasts, respectively, are shown. (B) Bar, 50 µm. (D) MDSCs treated with 50 µM of DEM had regeneration indices similar to that of myoblasts and statistically significant lower regeneration indices than untreated MDSCs. ANOVA; *p 0.05; n = 8 in each group; mean values ± SEM.

Myocardial infarctions were induced in adult wild-type C57 mice by ligating their left anterior descending artery and which was followed by immediately injecting both cell populations as previously reported (Oshima et al., 2005; Payne et al., 2007). Functional analysis was performed using echocardiography at 6 wk and histological analysis was performed at 8 wk to measure the amount of fibrosis, the degree of regeneration, and the capillary density at the injection site.

Cross sections of hearts were stained with Mason trichrome to measure the degree and area of fibrosis. On microscopic observation, infarcted hearts injected with DEM-treated MDSCs and PBS controls had comparable degrees of fibrosis, whereas both groups had more fibrosis than untreated MDSCs (Figure 6A, 1–3). These results were quantified by calculating the scar tissue ratio, defined as the ratio of the area of fibrosis compared with the total cross-sectional area of the heart. Infarcted hearts injected with MDSCs treated with DEM and PBS displayed large and comparable scar tissue ratios. In contrast, untreated MDSCs had a significantly smaller scar tissue ratio than both of these groups (p < 0.05; Figure 6A, 4). These results suggest that decreasing the antioxidant capacity of MDSCs also deteriorates the ability of MDSCs to improve cardiac wound healing and prevent adverse cardiac remodeling, such as scar tissue.

View larger version (41K): [in this window] [in a new window]   Figure 6. Decreasing the antioxidant capacity of MDSCs decreases the ability of MDSCs to mitigate adverse remodeling after an induced myocardial infarction. MDSCs, DEM-treated MDSCs, or PBS was injected into the infarction site. Animals were sacrificed at 8 wk for histological analysis. (A) Mason trichrome staining was performed to measure fibrosis. Representative images of infarcted hearts injected with MDSCs (A1), MDSCs treated with DEM (A2), and PBS (A3) are shown. Arrowheads indicate the main areas of infarcted myocardium. Note the thin fibrotic walls in A2 and A3 compared with the small area of fibrosis in A1. Infarcted hearts injected with MDSCs had significantly less fibrosis than hearts injected with MDSCs treated with DEM or PBS as measured by the scar tissue ratio (A4). (A2) Bar, 1000 µm. (B) The vascularity of the infarcted area was measured by staining the sections for CD31, an endothelial cell marker. Representative images of the capillary density of the infarcted area of hearts injected with MDSCs (B1), MDSCs treated with DEM (B2), and PBS (B3) are shown. Arrowheads outline the myocardial wall. Note the reduced capillary density in the myocardium in B2 and B3 when compared with B1. The capillary density was measured by counting the number of capillaries per pixel area. The infarcted area of hearts injected with MDSCs had significantly higher capillary densities than hearts injected with MDSCs treated with DEM and PBS (B4). (B2) Bar, 50 µm. (A4 and B4) MDSCs + DEM, n = 6; MDSCs, n = 6; PBS control, n = 5. ANOVA; *p 0.05; mean values ± SEM.

Echocardiography was performed to compare left ventricle function 6 wk after infarction. Two-dimensional images were obtained at diastole and systole to observe the contraction of the myocardium. M-mode tracings were used to measure the EDD and ESD as previously described (Figure 7A; Oshima et al., 2005; Payne et al., 2007). No differences in left ventricular cavity size as measured by the area of the myocardium during diastole were observed among all three groups as assessed by EDA (Figure 7B), a result commonly observed in this type of experiments (Oshima et al., 2005; Payne et al., 2005). As assessed by FS and FAC, infarcted hearts injected with MDSCs had significantly better systolic function relative to the infarcted hearts injected with both MDSCs treated with DEM and PBS (p < 0.05). Measuring FS, infarcted hearts injected with MDSCs treated with DEM had statistically increased systolic function compared with hearts injected with PBS (p < 0.05). Measuring FAC, infarcted hearts injected with MDSCs treated with DEM had systolic function comparable to that of hearts injected with PBS (Figure 7, C and D). Together, the functional experiments suggest that when the antioxidant capacity of MDSCs is decreased, MDSCs have a limited ability to repair cardiac function.

View larger version (51K): [in this window] [in a new window]   Figure 7. Decreasing the antioxidant capacity of MDSCs decreases the ability of MDSCs to improve cardiac function after an induced myocardial infarction. After myocardial infarctions were induced, functional analysis was performed at 6 wk using echocardiography. (A) Representative echocardiograph images of one of the MDSC groups are shown to demonstrate functional measurements. Two-dimensional echocardiograph images of the left ventricle at diastole and systole used to calculate FAC are shown. The myocardium is outlined to demonstrate the change in area during contraction between diastole and systole. The widest diameter of the ventricle during diastole in the two-dimensional echocardiograph image, as indicated by the dashed line, was followed for a period of time over consecutive heartbeats as shown in the M-mode tracing. EDD and ESD were measured to calculate FS. (B) Infarcted hearts injected with MDSCs, MDSCs treated with DEM, and PBS all have similar values of EDA indicating these groups have comparable left ventricular cavity size after infarction. (C) Hearts injected with MDSCs have a significantly increased FS compared with MDSCs treated with DEM and the PBS control, indicating improved cardiac function. Infarcted hearts injected with MDSCs treated with DEM and PBS have comparable FS, indicating similar cardiac function after infarction. (D) Hearts injected with MDSCs have a significantly increased FAC compared with MDSCs treated with DEM and the PBS control indicating improved contractile function. Both groups of MDSCs have an increased FAC over the PBS control. (B–D) MDSCs+DEM, n = 8; MDSCs, n = 7; PBS control, n = 8. ANOVA; *p 0.05; mean values ± SEM.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

It was noted in this study that MDSCs were maintained at a higher passage number than myoblasts. MDSCs can be maintained in culture through 200 population doublings with no evidence of neoplastic transformation, chromosome abnormalities, or decrease in regenerative capacity (Deasy et al., 2005). There is no evidence that MDSCs obtain increased antioxidant capacity with increasing passage number; indeed, just the opposite has been reported in multiple groups that have demonstrated that low passage cell populations have an increased resistance to stress, antioxidant capacity, and ability to withstand adverse environmental conditions compared with higher passaged cell populations (Luce and Cristofalo, 1992; Yuan et al., 1996; Kaneko et al., 2001; Gurjala et al., 2005; Dowling et al., 2006).

Inflammation clearly is one of the most important hurdles to overcome in order to increase the efficacy of cellular therapies. A major source of the destructive power of inflammation is the direct and indirect generation of ROS and free radicals after the inflammatory cytokine response (Dhalla et al., 1999). In myogenic cell transplantation, a large percentage of myoblasts die within 24–48 h after transplantation into both skeletal and myocardial muscles, which correlates with the time frame of an acute inflammatory response that is observed at the site of injection (Beauchamp et al., 1999; Gussoni et al., 1999; Oshima et al., 2005; Urish et al., 2005). Furthermore and relevant to the cardiac studies presented herein, the pathological hallmark after a myocardial infarction is a rapid and strong inflammatory process (Dhalla et al., 1999; Kaminski et al., 2002; Nian et al., 2004).

We postulated that one of the mechanisms behind the MDSCs' superior regenerative capacity may involve a resistance to these stresses that occurs during cell transplantation. MDSCs consistently had lower rates of cell death and increased rates of differentiation and fusion after exposure to both H₂O₂ and TNF- when compared with myoblasts. These results demonstrate that MDSCs possess different and perhaps enhanced mechanisms of handling oxidative stress and inflammation compared with myoblasts.

Different groups have reported that oxidative stress can either induce a "differentiation checkpoint" (Puri et al., 2002) or permanently force a cell into a state of senescence (Chen et al., 2004). A differentiation checkpoint is similar to a cell cycle check-point in that differentiation is arrested until the damage has been repaired and the stress has dissipated. After exposure to inflammatory cytokines such as TNF- or IL-1, myogenic differentiation is inhibited through activation of the nuclear factor kappa B (NF-B) pathway (Guttridge et al., 1999; Langen et al., 2004). Inhibiting the activation of NF-B in Mdx mice, a mouse model of Duchenne muscular dystrophy, improves the ability of muscle progenitor cells to proliferate, form myotubes, and repair damaged muscle fibers (Kumar and Boriek, 2003; Acharyya et al., 2007). Further, direct exposure to oxidative stress inhibits myoblast differentiation through the same mechanism of NF-B activation (Catani et al., 2004).

Given that the NF-B pathways may be activated by both oxidative and inflammatory stress, our results support these observations. MDSCs demonstrated no change in their ability to fuse and form myotubes after in vitro exposure to oxidative stress in the form of H₂O₂ and TNF-. Myoblasts exposed to increased levels of oxidative stress and an inflammatory cytokine had a temporary decrease in the ability to differentiate, and when this stress was removed, myoblasts resumed differentiation. If myogenic differentiation is inhibited via the NF-B pathway, this implies that MDSCs may maintain their rate of differentiation after they are exposed to inflammatory and oxidative stresses by mitigating NF-B activation.

The phenotypic differences in survival and differentiation between MDSCs and myoblasts could be explained by the antioxidant capacity of each population. When the GSH level of MDSCs was reduced to levels similar to myoblasts to decrease antioxidant capacity, MDSCs' capacity to regenerate both skeletal and cardiac muscles was decreased to that of myoblasts. We also showed that these differences were manifested at a functional level in the myocardial infarction animal model. The suggestion that stem cells have an increased resistance to oxidative stress compared with their more differentiated progeny has been described previously (Dernbach et al., 2004; He et al., 2004). Other studies focused on the importance of stress in the transplantation process by genetically engineering the transplanted cell population to resist the effects of inflammation and stress, most notably with heat-shock proteins (Suzuki et al., 2000; Zhang et al., 2001). In this study we extend these findings by showing that the MDSCs' superior antioxidant capacity not only improves its regenerative capacity in skeletal and cardiac muscle but enhances the host tissue's ability to mitigate adverse remodeling in the case of infracted myocardium.

The term "stemness" has been used to describe the properties that define a stem cell and its molecular signature (Ivanova et al., 2002; Ramalho-Santos et al., 2002; Dernbach et al., 2004). These include the upregulation of genes responsible for self-renewal, long-term proliferation, and multipotent differentiation. An emerging stem cell property is its antioxidant capacity and corresponding response to oxidative and inflammatory stresses. After an injury, a toxic environment can be created from inflammation, ischemia, reperfusion, and the ensuing inflammatory cytokine storm. A stem cell's ability to function as a regenerative building block depends on its capacity to withstand and perhaps respond to this noxious environment.

In this study we have observed an increased antioxidant capacity in MDSCs that we believe is a critical if not necessary feature of their superior regeneration capacity in skeletal and cardiac muscles. This feature not only suggests that the MDSCs may have a higher stress capacity than myoblasts, but it also lends credence to our emerging understanding of how an enhanced resistance to oxidative and inflammatory stress pertains to the concept of cellular "stemness."

	ACKNOWLEDGMENTS

 
The authors thank A. Logar for technical assistance, and Dr. Bruno Péault (Pediatrics, University of Pittsburgh) for insightful discussions. This work was supported by the Jesse's Journey Foundation, the Muscular Dystrophy Association, the National Institutes of Health (NIH) Grants R01 AR49684 and R01 AR47973, the William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh, and the Henry J. Mankin Chair at the University of Pittsburgh.

	Footnotes

 
This was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-03-0274) on November 12, 2008.

Address correspondence to: Johnny Huard (jhuard{at}pitt.edu)

Abbreviations used: DEM, diethyl maleate; EDA, end-diastolic area; EDD, end-diastolic dimension; ESD, end-systolic dimension; MHC, skeletal fast myosin heavy chain; FAC, fractional area change; FS, fractional shortening; GSH, glutathione; MCB, monochlorobimane; MDSC, muscle-derived stem cell; NF-B, nuclear factor kappa B; ROS, reactive oxygen species; SOD, superoxide dismutase.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

 
Acharyya, S. et al. (2007). Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J. Clin. Invest 117, 889–901.[CrossRef][Medline]

Assmus, B. et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med 355, 1222–1232.[Abstract/Free Full Text]

Bahnson, A. L. et al. (2005). Automated measurement of cell motility and proliferation. BMC Cell Biol 6, 19.[CrossRef][Medline]

Beauchamp, J. R., Morgan, J. E., Pagel, C. N., and Partridge, T. A. (1994). Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve 18, (Suppl.), 261.[CrossRef]

Beauchamp, J. R., Morgan, J. E., Pagel, C. N., and Partridge, T. A. (1999). Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol 144, 1113–1122.[Abstract/Free Full Text]

Blackwell, T. S., Christman, J. W., Hagan, T., Price, P., Edens, T., Morris, P. E., Wolff, S. N., Goodman, S. A., and Christman, B. W. (2000). Oxidative stress and NF-kappaB activation: correlation in patients following allogeneic bone marrow transplantation. Antioxid. Redox. Signal 2, 93–102.[Medline]

Bottino, R., Balamurugan, A. N., Tse, H., Thirunavukkarasu, C., Ge, X., Profozich, J., Milton, M., Ziegenfuss, A., Trucco, M., and Piganelli, J. D. (2004). Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 53, 2559–2568.[CrossRef][Medline]

Carden, D. L., and Granger, D. N. (2000). Pathophysiology of ischaemia-reperfusion injury. J. Pathol 190, 255–266.[CrossRef][Medline]

Catani, M. V., Savini, I., Duranti, G., Caporossi, D., Ceci, R., Sabatini, S., and Avigliano, L. (2004). Nuclear factor kappaB and activating protein 1 are involved in differentiation-related resistance to oxidative stress in skeletal muscle cells. Free Radic, Biol. Med 37, 1024–1036.[CrossRef][Medline]

Cerletti, M., Jurga, S., Witczak, C. A., Hirshman, M. F., Shadrach, J. L., Goodyear, L. J., and Wagers, A. J. (2008). Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134, 37–47.

Chanock, S. J., el Benna, J., Smith, R. M., and Babior, B. M. (1994). The respiratory burst oxidase. J. Biol. Chem 269, 24519–24522.[Free Full Text]

Chen, J. H., Stoeber, K., Kingsbury, S., Ozanne, S. E., Williams, G. H., and Hales, C. N. (2004). Loss of proliferative capacity and induction of senescence in oxidatively stressed human fibroblasts. J. Biol. Chem 279, 49439–49446.[Abstract/Free Full Text]

Crisan, M., Deasy, B., Gavina, M., Zheng, B., Lazzari, L., and Peault, B. (2008). Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 86, 295–309.[CrossRef][Medline]

Deasy, B. M., Gharaibeh, B. M., Pollett, J. B., Jones, M. M., Lucas, M. A., Kanda, Y., and Huard, J. (2005). Long-term self-renewal of postnatal muscle-derived stem cells. Mol. Biol. Cell 16, 3323–3333.[Abstract/Free Full Text]

Deasy, B. M., Jankowski, R. J., Payne, T. R., Cao, B., Goff, J. P., Greenberger, J. S., and Huard, J. (2003). Modeling stem cell population growth: incorporating terms for proliferative heterogeneity. Stem Cells 21, 536–545.[Abstract/Free Full Text]

Deasy, B. M. et al. (2007). A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J. Cell Biol 177, 73–86.[Abstract/Free Full Text]

Deasy, B. M., Qu-Peterson, Z., Greenberger, J. S., and Huard, J. (2002). Mechanisms of muscle stem cell expansion with cytokines. Stem Cells 20, 50–60.[Abstract/Free Full Text]

Dellavalle, A. et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol 9, 255–267.[CrossRef][Medline]

Dernbach, E., Urbich, C., Brandes, R. P., Hofmann, W. K., Zeiher, A. M., and Dimmeler, S. (2004). Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 104, 3591–3597.[Abstract/Free Full Text]

Dhalla, N. S., Golfman, L., Takeda, S., Takeda, N., and Nagano, M. (1999). Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review. Can. J. Cardiol 15, 587–593.[Medline]

Dowling, P., O'Driscoll, L., O'Sullivan, F., Dowd, A., Henry, M., Jeppesen, P. B., Meleady, P., and Clynes, M. (2006). Proteomic screening of glucose-responsive and glucose non-responsive MIN-6 beta cells reveals differential expression of proteins involved in protein folding, secretion and oxidative stress. Proteomics 6, 6578–6587.[CrossRef][Medline]

Evens, A. M., Mehta, J., and Gordon, L. I. (2004). Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant 34, 561–571.[CrossRef][Medline]

Fan, Y., Maley, M., Beilharz, M., and Grounds, M. (1996). Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19, 853–860.[CrossRef][Medline]

Gharaibeh, B., Lu, A., Tebbets, J. C., Zheng, B., Feduska, J. M., Crisan, M., Peault, B., Cummins, J., and Huard, J. (2008). Isolation of a slowly adhering cell fraction containing stems cells from murine skeletal muscle by the preplate technique. Nat. Protocol 3, 1501–1509.[CrossRef]

Gurjala, A. N., Liu, W. R., Mogford, J. E., Procaccini, P. S., and Mustoe, T. A. (2005). Age-dependent response of primary human dermal fibroblasts to oxidative stress: cell survival, pro-survival kinases, and entrance into cellular senescence. Wound Repair Regen 13, 565–575.[CrossRef][Medline]

Gussoni, E., Blau, H. M., and Kunkel, L. M. (1997). The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med 3, 970–977.[CrossRef][Medline]

Gussoni, E., Soneoka, Y., Strickland, C. D., Buzney, E. A., Khan, M. K., Flint, A. F., Kunkel, L. M., and Mulligan, R. C. (1999). Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390–394.[CrossRef][Medline]

Gute, D. C., Ishida, T., Yarimizu, K., and Korthuis, R. J. (1998). Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol. Cell Biochem 179, 169–187.[CrossRef][Medline]

Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., and Baldwin, A. S., Jr. (1999). NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol 19, 5785–5799.[Abstract/Free Full Text]

Hagege, A. A. et al. (2006). Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114, I108–113.[Medline]

He, T., Peterson, T. E., Holmuhamedov, E. L., Terzic, A., Caplice, N. M., Oberley, L. W., and Katusic, Z. S. (2004). Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb. Vasc. Biol 24, 2021–2027.[Abstract/Free Full Text]

Hempel, S. L., Buettner, G. R., O'Malley, Y. Q., Wessels, D. A., and Flaherty, D. M. (1999). Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2',7'-dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2',7'-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol. Med 27, 146–159.[CrossRef][Medline]

Huard, J., Roy, R., Guerette, B., Verreault, S., Tremblay, G., and Tremblay, J. P. (1994). Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection. Muscle Nerve 17, 224–234.[CrossRef][Medline]

Ivanova, N. B., Dimos, J. T., Schaniel, C., Hackney, J. A., Moore, K. A., and Lemischka, I. R. (2002). A stem cell molecular signature. Science 298, 601–604.[Abstract/Free Full Text]

Jankowski, R. J., Deasy, B. M., Cao, B., Gates, C., and Huard, J. (2002). The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J. Cell Sci 115, 4361–4374.[Abstract/Free Full Text]

Jankowski, R. J., Haluszczak, C., Trucco, M., and Huard, J. (2001). Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum. Gene Ther 12, 619–628.[CrossRef][Medline]

Jankowski, R. J., and Huard, J. (2002). Myogenic cellular transplantation and regeneratioin: sorting through progenitor heterogeneity. Panminerva Medica 46, 81–91.

Kaminski, K. A., Bonda, T. A., Korecki, J., and Musial, W. J. (2002). Oxidative stress and neutrophil activation—the two keystones of ischemia/reperfusion injury. Int. J. Cardiol 86, 41–59.[CrossRef][Medline]

Kaneko, T., Tahara, S., Taguchi, T., and Kondo, H. (2001). Accumulation of oxidative DNA damage, 8-oxo-2'-deoxyguanosine, and change of repair systems during in vitro cellular aging of cultured human skin fibroblasts. Mutat. Res 487, 19–30.[Medline]

Kumar, A., and Boriek, A. M. (2003). Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 17, 386–396.[Abstract/Free Full Text]

Langen, R. C., Van Der Velden, J. L., Schols, A. M., Kelders, M. C., Wouters, E. F., and Janssen-Heininger, Y. M. (2004). Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J 18, 227–237.[Abstract/Free Full Text]

Lee, J. Y. et al. (2000). Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J. Cell Biol 150, 1085–1100.[Abstract/Free Full Text]

Luce, M. C., and Cristofalo, V. J. (1992). Reduction in heat shock gene expression correlates with increased thermosensitivity in senescent human fibroblasts. Exp. Cell Res 202, 9–16.[CrossRef][Medline]

Lunde, K. et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med 355, 1199–1209.[Abstract/Free Full Text]

Makazan, Z., Saini, H. K., and Dhalla, N. S. (2007). Role of oxidative stress in alterations of mitochondrial function in ischemic-reperfused hearts. Am. J. Physiol. Heart Circ. Physiol 292, H1986–H1994.[Abstract/Free Full Text]

Mendell, J. R. et al. (1995). Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med 333, 832–838.[Abstract/Free Full Text]

Nian, M., Lee, P., Khaper, N., and Liu, P. (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res 94, 1543–1553.[Abstract/Free Full Text]

Nishino, T. (1994). The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J. Biochem 116, 1–6.[Abstract/Free Full Text]

Oshima, H., Payne, T. R., Urish, K. L., Sakai, T., Ling, Y., Gharaibeh, B., Tobita, K., Keller, B. B., Cummins, J. H., and Huard, J. (2005). Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol. Ther 12, 1130–1141.[CrossRef][Medline]

Payne, T. R., Oshima, H., Okada, M., Momoi, N., Tobita, K., Keller, B. B., Peng, H., and Huard, J. (2007). A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J. Am. Coll. Cardiol 50, 1677–1684.[Abstract/Free Full Text]

Payne, T. R., Oshima, H., Sakai, T., Ling, Y., Gharaibeh, B., Cummins, J., and Huard, J. (2005). Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther 12, 1264–1274.[CrossRef][Medline]

Peault, B., Rudnicki, M., Torrente, Y., Cossu, G., Tremblay, J. P., Partridge, T., Gussoni, E., Kunkel, L. M., and Huard, J. (2007). Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol. Ther 15, 867–877.[CrossRef][Medline]

Plummer, J. L., Smith, B. R., Sies, H., and Bend, J. R. (1981). Chemical depletion of glutathione in vivo. Methods Enzymol 77, 50–59.[Medline]

Puri, P. L., Bhakta, K., Wood, L. D., Costanzo, A., Zhu, J., and Wang, J. Y. (2002). A myogenic differentiation checkpoint activated by genotoxic stress. Nat. Genet 32, 585–593.[CrossRef][Medline]

Qu, Z., Balkir, L., van Deutekom, J. C., Robbins, P. D., Pruchnic, R., and Huard, J. (1998). Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol 142, 1257–1267.[Abstract/Free Full Text]

Qu-Petersen, Z., Deasy, B., Jankowski, R., Ikezawa, M., Cummins, J., Pruchnic, R., Mytinger, J., Cao, B., Gates, C., Wernig, A., and Huard, J. (2002). Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol 157, 851–864.[Abstract/Free Full Text]

Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., and Melton, D. A. (2002). "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298, 597–600.[Abstract/Free Full Text]

Rando, T. A., and Blau, H. M. (1994). Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol 125, 1275–1287.[Abstract/Free Full Text]

Schachinger, V. et al. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med 355, 1210–1221.[Abstract/Free Full Text]

Suzuki, K., Murtuza, B., Beauchamp, J. R., Smolenski, R. T., Varela-Carver, A., Fukushima, S., Coppen, S. R., Partridge, T. A., and Yacoub, M. H. (2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 18, 1153–1155.[Abstract/Free Full Text]

Suzuki, K., Smolenski, R. T., Jayakumar, J., Murtuza, B., Brand, N. J., and Yacoub, M. H. (2000). Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation 102, III216–221.[Medline]

Tamaki, T., Akatsuka, A., Ando, K., Nakamura, Y., Matsuzawa, H., Hotta, T., Roy, R. R., and Edgerton, V. R. (2002). Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J. Cell Biol 157, 571–577.[Abstract/Free Full Text]

Tamaki, T., Akatsuka, A., Okada, Y., Uchiyama, Y., Tono, K., Wada, M., Hoshi, A., Iwaguro, H., Iwasaki, H., Oyamada, A., and Asahara, T. (2008a). Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS ONE 3, e1789.[CrossRef][Medline]

Tamaki, T., Okada, Y., Uchiyama, Y., Tono, K., Masuda, M., Nitta, M., Hoshi, A., and Akatsuka, A. (2008b). Skeletal muscle-derived CD34(+)/45(–) and CD34(-)/45(-) stem cells are situated hierarchically upstream of Pax7(+) cells. Stem Cells Dev 17, 653–667.[CrossRef][Medline]

Tamaki, T., Okada, Y., Uchiyama, Y., Tono, K., Masuda, M., Wada, M., Hoshi, A., Ishikawa, T., and Akatsuka, A. (2007). Clonal multipotency of skeletal muscle-derived stem cells between mesodermal and ectodermal lineage. Stem Cells 25, 2283–2290.[Abstract/Free Full Text]

Tavian, M., Zheng, B., Oberlin, E., Crisan, M., Sun, B., Huard, J., and Peault, B. (2005). The vascular wall as a source of stem cells. Ann. NY Acad. Sci 1044, 41–50.[CrossRef][Medline]

Taylor, D. A., Atkins, B. Z., Hungspreugs, P., Jones, T. R., Reedy, M. C., Hutcheson, K. A., Glower, D. D., and Kraus, W. E. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med 4, 929–933.[CrossRef][Medline]

Tremblay, J. P., Malouin, F., Roy, R., Huard, J., Bouchard, J. P., Satoh, A., and Richards, C. L. (1993). Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2, 99–112.[Medline]

Urish, K. L., Kanda, Y., and Huard, J. (2005). Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration. Curr. Top. Dev. Biol 68, 263–280.[CrossRef][Medline]

Vreugdenhil, G., Lowenberg, B., Van Eijk, H. G., and Swaak, A. J. (1992). Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur. J. Clin. Invest 22, 488–493.[Medline]

Yoo, T. S., Ackerman, M. J., Lorensen, W. E., Schroeder, W., Chalana, V., Aylward, S., Metaxes, D., and Whitaker, R. (2002). Engineering and Algorithm Design for an Image Processing API: A Technical Report on ITK—The Insight Toolkit, Amsterdam: IOS Press.

Young, H. E. et al. (2001). Clonogenic analysis reveals reserve stem cells in postnatal mammals: I. Pluripotent mesenchymal stem cells. Anat. Rec 263, 350–360.[CrossRef][Medline]

Yuan, H., Kaneko, T., and Matsuo, M. (1996). Increased susceptibility of late passage human diploid fibroblasts to oxidative stress. Exp. Gerontol 31, 465–474.[CrossRef][Medline]

Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., and Murry, C. E. (2001). Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell Cardiol 33, 907–921.[CrossRef][Medline]

Zheng, B. et al. (2007). Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat. Biotechnol 25, 1025–1034.[CrossRef][Medline]

This Article Abstract Full Text (PDF) Supplemental Materials All Versions of this Article: E08-03-0274v1 20/1/509    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Urish, K. L. Articles by Huard, J. Search for Related Content PubMed PubMed Citation Articles by Urish, K. L. Articles by Huard, J.